Dermatology · Tulsa, OK
NPI
1891781779
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2121 E 21st St
Tulsa, OK, 74114
Phone (918) 749-2261
Groups this clinician bills Medicare through
Medicare paid, 2024
$320K
6,698 services
Medicare patients, 2024
1,492
Average age 76
Drug cost, 2024
$1.9M
3,133 prescriptions
Company payments, 2025
$62K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George W Monks was code 99213 (office e&m - established), 1,792 times for 1,111 patients. In total George W Monks billed 6,698 services in 58 codes, and Medicare paid $320K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,792 | 1,111 | $59.58 | $107K |
| 17003 Destruction Skin Lesion | Office | 1,781 | 380 | $4.60 | $8,192 |
| 17000 Destruction Skin Lesion | Office | 870 | 577 | $35.94 | $31K |
| 17110 Destruction Skin Lesion | Office | 702 | 565 | $73.54 | $52K |
| 99214 Office E&M - Established | Office | 508 | 393 | $84.94 | $43K |
| 99203 Office E&M - New | Office | 211 | 211 | $66.29 | $14K |
| 11102 Skin Biopsy | Office | 205 | 183 | $62.53 | $13K |
| 17262 Destruction Skin Lesion | Office | 66 | 60 | $119.24 | $7,870 |
| 99204 Office E&M - New | Office | 55 | 55 | $92.45 | $5,085 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 53 | 12 | $0.07 | $3.75 |
| 96372 Injection Administration | Office | 46 | 26 | $9.78 | $450 |
| 99212 Office E&M - Established | Office | 41 | 40 | $35.99 | $1,476 |
| 17282 Destruction Skin Lesion | Office | 40 | 38 | $142.99 | $5,720 |
| 17281 Destruction Skin Lesion | Office | 35 | 34 | $117.26 | $4,104 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 30 | 21 | $11.15 | $334 |
By year: 2022 $285K for 6,485 services; 2023 $340K for 7,468 services; 2024 $320K for 6,698 services.
Medicare prescription drug claims, 2024
In 2024, the drug George W Monks prescribed most often to Medicare patients was Triamcinolone Acetonide, with 716 prescriptions and refills. In total George W Monks wrote 3,133 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 716 | 819 | 455 | $8,582 |
| Imiquimod Generic | 339 | 363 | 271 | $13K |
| Ketoconazole Generic | 254 | 284 | 110 | $4,191 |
| Fluconazole Generic | 200 | 202 | 146 | $594 |
| Minoxidil Generic | 181 | 346 | 55 | $1,070 |
| Hydrocortisone Generic | 143 | 155 | 95 | $1,103 |
| Prednisone Generic | 140 | 142 | 88 | $537 |
| Doxycycline Hyclate Generic | 109 | 115 | 63 | $1,266 |
| Minocycline Hcl Generic | 96 | 119 | 46 | $2,007 |
| Metronidazole Generic | 93 | 112 | 51 | $3,294 |
| Mupirocin Generic | 73 | 73 | 53 | $544 |
| Valacyclovir Valacyclovir Hcl | 64 | 81 | 33 | $2,588 |
| Ciclopirox Ciclopirox Olamine | 61 | 75 | 44 | $2,289 |
| Terbinafine Hcl Generic | 59 | 61 | 44 | $538 |
| Clobetasol Propionate Generic | 52 | 60 | 32 | $2,702 |
Brand drugs: 239 claims; generic drugs: 2,894 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George W Monks $62K ($62K in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $24K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 37 | $24K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 29 | $23K |
| Amgen Inc. AMGN | 13 | $10K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $1,613 |
| Janssen Biotech, Inc. JNJ | 20 | $618 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $413 |
| UCB, Inc. UCB.BR | 18 | $304 |
| Arcutis Biotherapeutics, Inc. ARQT | 17 | $289 |
| Lilly USA, LLC LLY | 16 | $249 |
| LEO Pharma Inc. | 11 | $219 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.